Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia

Clinical Infectious Diseases

Volumn 28, Issue 4, 1999, Pages 901-905

  Salmon Ceron, D ^a   Fillet, A M ^a   Aboulker, J P ^a   Gerard, L ^a   Houhou, N ^a   Carriere, I ^a   Ostinelli, J ^a   Vilde, J L ^a   Brun Vezinet, F ^a   Leport, C ^a  

^a université Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET;

ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE MARKER; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIREMIA; VIRUS CULTURE; VIRUS LOAD;

EID: 0032899465     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515223     Document Type: Article

References (12)